Cholesterol drug news, articles and information:
 | 9/4/2008 - Documents on the FDA Web site reveal that pharmaceutical companies Merck and Schering-Plough conducted numerous safety studies on the popular cholesterol drug Zetia but did not publish the results, which suggested that the drug may cause liver damage when mixed with statins.
Zetia is a trade name...
|
 | 5/1/2008 - Patients who take the cholesterol drug torcetrapid, intended to increase levels of HDL ("good") cholesterol and lower LDL ("bad") cholesterol levels, have a 58 percent higher risk of death than similar patients who do not take the drug, according to a study led by researchers at the Heart Research Institute...
|
 | 12/11/2006 - Pharmaceutical giant Pfizer announced that it has ended a clinical trial for the highly anticipated cholesterol drug torcetrapib -- which raises levels of "healthy" HDL cholesterol -- after a high number of patients participating in the trial died or experienced cardiovascular problems.
Pfizer, the...
|
Concept-related articles:Cholesterol:The FDA:FDA:Vioxx:Food and Drug Administration:Food:Risk:Safety:Evidence:Risks:Drug:Medical:Merck:Medicine:Drugs:Companies:
|
 |
Concepts related to Cholesterol drug
|
|